T2 Biosystems, Inc. (TTOO): Price and Financial Metrics


T2 Biosystems, Inc. (TTOO)

Today's Latest Price: $1.40 USD

0.12 (-7.89%)

Updated Jul 2 4:00pm

Add TTOO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TTOO Stock Summary

  • T2 Biosystems Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 5.64% of US listed stocks.
  • TTOO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 5.1% of US stocks.
  • The volatility of T2 Biosystems Inc's share price is greater than that of 95.77% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to T2 Biosystems Inc are SENS, FLXN, INSM, URG, and PRTK.
  • Visit TTOO's SEC page to see the company's official filings. To visit the company's web site, go to www.t2biosystems.com.
TTOO Daily Price Range
TTOO 52-Week Price Range

TTOO Stock Price Chart Technical Analysis Charts


TTOO Price/Volume Stats

Current price $1.40 52-week high $3.21
Prev. close $1.52 52-week low $0.24
Day low $1.36 Volume 31,959,524
Day high $1.56 Avg. volume 11,386,761
50-day MA $0.97 Dividend yield N/A
200-day MA $1.27 Market Cap 167.35M

T2 Biosystems, Inc. (TTOO) Company Bio


T2 Biosystems develops diagnostic products and product candidates for the detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company was founded in 2006 and is based in Lexington, Massachusetts.


TTOO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

TTOO Latest Social Stream


Loading social stream, please wait...

View Full TTOO Social Stream

Latest TTOO News From Around the Web

Below are the latest news stories about T2 Biosystems Inc that investors may wish to consider to help them evaluate TTOO as an investment opportunity.

Company News for Jul 2, 2020

Companies in the news are: M, FDX, BYND, TTOO

Yahoo | July 2, 2020

The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC Therapeutics SA (NYSE: ADCT ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced agreement with the FDA regarding Phase 2 study of Parkinsonian disorder drug) Calliditas Therapeutics AB ADR (NASDAQ: CALT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) - partner Seattle Genetics, Inc. (NASDAQ: SGEN ) announced positive results for antibody-drug conjugate for cervical cancer Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) ( reacted to a positive analyst action) Legend Biotech Corp (NASDAQ: LEGN ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax...

Benzinga | July 1, 2020

T2 Biosystems Solidifies Its Position as a COVID-19 Stock With New Test

No summary available.

24/7 Wall street | July 1, 2020

T2 Biosystems launches COVID-19 molecular diagnostic test in U.S.

T2 Biosystems has completed the validation of its T2SARS-CoV-2 Panel, its molecular test for COVID-19. Commercial launch is underway under emergency use authorizationThe T2SARS-CoV-2 Panel runs on the Company’s T2Dx Instrument, an automated, random access system capable of performing seven tests simultaneously. Provides sample-to-answer results in less than two hours, utilizing a...

Seeking Alpha | June 30, 2020

T2 Biosystems Announces U.S. Launch of COVID-19 Diagnostic Test

T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel. The test was developed by T2 Biosystems under a license agreement with the Center of Discovery and Innovation at Hackensack Meridian Health and is being commercially distributed after validation meeting requirements for an Emergency Use Authorization (EUA) request to FDA. The T2SARS-CoV-2 Panel runs on the Company’s FDA-cleared T2Dx® Instrument, which is a fully-automated, random access system capable of performing seven tests simultaneously.

Yahoo | June 30, 2020

Read More 'TTOO' Stories Here

TTOO Price Returns

1-mo 18.64%
3-mo 176.95%
6-mo 17.65%
1-year -16.67%
3-year -55.56%
5-year -91.39%
YTD 19.66%
2019 -61.13%
2018 -26.94%
2017 -21.67%
2016 -51.92%
2015 -43.14%

Continue Researching TTOO

Want to see what other sources are saying about T2 Biosystems Inc's financials and stock price? Try the links below:

T2 Biosystems Inc (TTOO) Stock Price | Nasdaq
T2 Biosystems Inc (TTOO) Stock Quote, History and News - Yahoo Finance
T2 Biosystems Inc (TTOO) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8088 seconds.